Toxoplasma gondii uses sulfated proteoglycans for substrate and host cell attachment - PubMed (original) (raw)
Toxoplasma gondii uses sulfated proteoglycans for substrate and host cell attachment
V B Carruthers et al. Infect Immun. 2000 Jul.
Abstract
Toxoplasma gondii is an obligate intracellular parasite that actively invades a wide variety of vertebrate cells, although the basis of this pervasive cell recognition is not understood. We demonstrate here that binding to the substratum and to host cells is partially mediated by interaction with sulfated glycosaminoglycans (GAGs). Addition of excess soluble GAGs blocked parasite attachment to serum-coated glass, thereby preventing gliding motility of extracellular parasites. Similarly, excess soluble GAGs decreased the attachment of parasites to human host cells from a variety of lineages, including monocytic, fibroblast, endothelial, epithelial, and macrophage cells. The inhibition of parasite attachment by GAGs was observed with heparin and heparan sulfate and also with chondroitin sulfates, indicating that the ligands for attachment are capable of recognizing a broad range of GAGs. The importance of sulfated proteoglycan recognition was further supported by the demonstration that GAG-deficient mutant host cells, and wild-type cells treated enzymatically to remove GAGs, were partially resistant to parasite invasion. Collectively, these studies reveal that sulfated proteoglycans are one determinant used for substrate and cell recognition by Toxoplasma. The widespread distribution of these receptors may contribute to the broad host and tissue ranges of this highly successful intracellular parasite.
Figures
FIG. 1
IF detection of trails produced by gliding Toxoplasma on protein-coated glass. Addition of heparin (Hep), heparan sulfate (HepS), CSA, and CSC at 25 mg/ml significantly inhibited both substrate attachment and the formation of trails. The trails were detected by staining for the surface antigen SAG1 as described in Materials and Methods. CTL, gliding in medium in the absence of additions. Bars, 5 μm.
FIG. 2
GAGs inhibit gliding motility. Incubation of parasites with increasing concentrations (6.2, 12.5, and 25 mg/ml) of heparin (Hep), heparan sulfate (HepS), CSA, CSC, and dextran sulfate (DS), but not dextran (D), resulted in a significant inhibition of attachment to serum-coated glass (A) and relative gliding as monitored by the formation of trails (B). Control represents the extent of attachment or gliding in medium lacking additives. The data are reported as average percentages of control plus SE; n = 3.
FIG. 3
Soluble GAGs disrupt Toxoplasma attachment to human fibroblasts in a biphasic, dose-dependent manner. (A) CSC, CSA, or the synthetic polyanion dextran sulfate (DS) slightly enhanced attachment at concentrations of <1 mg/ml but then markedly inhibited attachment at higher concentrations, whereas nonsulfated dextran (D) had little effect. (B) Heparin (Hep) also showed a biphasic response, enhancing binding at low doses and inhibiting it at higher concentrations. Heparan sulfate (HS) as well as de-N-sulfated heparin (dNS) competed for binding of parasites to host cell monolayers only at higher concentrations, while fucoidin (Fuc) (a polymer of sulfated
l
-fucose) had little affect. HFF monolayers in 96-well plates were preincubated with 0 to 20 mg of GAGs/ml, and the attachment of parasites was quantified using a colorimetric assay for β-Gal activity. The data are reported as mean percent inhibition, where untreated controls represent 100%; n = 3.
FIG. 4
GAG-deficient host cells (pgsA-745) were ∼40% less susceptible to infection by parasites than wild-type CHO-K1 host cells (Ctl), and their residual capacity for attachment was unaffected by soluble GAGs. Wild-type and mutant host cells were pretreated with medium alone or 5 mg of heparin (H), dextran sulfate (DS), or dextran (D) per ml, and host-cell-associated parasites were quantified by IF microscopy. The data are expressed as the mean number of parasites per host cell plus SE; n = 3. ∗∗, statistically significant at a P value of ≤0.01 (Student's t test).
FIG. 5
Inhibition of parasite attachment to HFFs following enzymatic treatments to remove cell surface GAGs. Treatment with heparinase I (HepI) at 1.7 × 10−3 IU/ml or 1.7 × 10−4 IU/ml significantly reduced parasite attachment (∗∗, P ≤ 0.01). Treatment with heparinase III (HepIII) reduced parasite attachment at 1.7 × 10−3 IU/ml and to a lesser extent at 1.7 × 10−4 IU/ml (∗, P ≤ 0.05). Treatment with chondroitinase ABC (Case-ABC) at 1 IU/ml reduced parasite attachment only slightly. The data are expressed as the mean plus SE; n = 2.
Similar articles
- A Toxoplasma lectin-like activity specific for sulfated polysaccharides is involved in host cell infection.
Ortega-Barria E, Boothroyd JC. Ortega-Barria E, et al. J Biol Chem. 1999 Jan 15;274(3):1267-76. doi: 10.1074/jbc.274.3.1267. J Biol Chem. 1999. PMID: 9880495 - Toxoplasma gondii secretory proteins bind to sulfated heparin structures.
Azzouz N, Kamena F, Laurino P, Kikkeri R, Mercier C, Cesbron-Delauw MF, Dubremetz JF, De Cola L, Seeberger PH. Azzouz N, et al. Glycobiology. 2013 Jan;23(1):106-20. doi: 10.1093/glycob/cws134. Epub 2012 Sep 20. Glycobiology. 2013. PMID: 22997241 - Matrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing.
Kosir MA, Quinn CC, Wang W, Tromp G. Kosir MA, et al. J Surg Res. 2000 Jul;92(1):45-52. doi: 10.1006/jsre.2000.5840. J Surg Res. 2000. PMID: 10864481 - Cell attachment and entry by Toxoplasma gondii.
Joiner K. Joiner K. Behring Inst Mitt. 1991 Feb;(88):20-6. Behring Inst Mitt. 1991. PMID: 2049038 Review. - Host cell invasion by the opportunistic pathogen Toxoplasma gondii.
Carruthers VB. Carruthers VB. Acta Trop. 2002 Feb;81(2):111-22. doi: 10.1016/s0001-706x(01)00201-7. Acta Trop. 2002. PMID: 11801218 Review.
Cited by
- The trophoblast surface becomes refractory to adhesion by congenitally transmitted Toxoplasma gondii and Listeria monocytogenes during cytotrophoblast to syncytiotrophoblast development.
da Silva RJ, Cabo LF, George JL, Cahoon LA, Yang L, Coyne CB, Boyle JP. da Silva RJ, et al. mSphere. 2024 Jun 25;9(6):e0074823. doi: 10.1128/msphere.00748-23. Epub 2024 May 21. mSphere. 2024. PMID: 38771057 Free PMC article. - Requirement of microtubules for secretion of a micronemal protein CpTSP4 in the invasive stage of the apicomplexan Cryptosporidium parvum.
Wang D, Jiang P, Wu X, Zhang Y, Wang C, Li M, Liu M, Yin J, Zhu G. Wang D, et al. mBio. 2024 Feb 14;15(2):e0315823. doi: 10.1128/mbio.03158-23. Epub 2024 Jan 24. mBio. 2024. PMID: 38265238 Free PMC article. - A heparin-binding protein of Plasmodium berghei is associated with merozoite invasion of erythrocytes.
Gao J, Jiang N, Zhang Y, Chen R, Feng Y, Sang X, Chen Q. Gao J, et al. Parasit Vectors. 2023 Aug 10;16(1):277. doi: 10.1186/s13071-023-05896-w. Parasit Vectors. 2023. PMID: 37563696 Free PMC article. - Host MOSPD2 enrichment at the parasitophorous vacuole membrane varies between Toxoplasma strains and involves complex interactions.
Ferrel A, Romano J, Panas MW, Coppens I, Boothroyd JC. Ferrel A, et al. mSphere. 2023 Aug 24;8(4):e0067022. doi: 10.1128/msphere.00670-22. Epub 2023 Jun 21. mSphere. 2023. PMID: 37341482 Free PMC article. - Chronic Toxoplasma gondii infection contributes to perineuronal nets impairment in the primary somatosensory cortex.
de Medeiros Brito RM, Meurer YDSR, Batista JAL, de Sá AL, de Medeiros Souza CR, de Souto JT, de Andrade-Neto VF. de Medeiros Brito RM, et al. Parasit Vectors. 2022 Dec 24;15(1):487. doi: 10.1186/s13071-022-05596-x. Parasit Vectors. 2022. PMID: 36566237 Free PMC article.
References
- Burg J L, Perlman D, Kasper L H, Ware P L, Boothroyd J C. Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii. J Immunol. 1988;141:3584–3591. - PubMed
- Carruthers V B, Giddings O K, Sibley L D. Secretion of micronemal proteins is associated with Toxoplasma invasion of host cells. Cell Microbiol. 1999;1:225–236. - PubMed
- Crane M J, Dvorak J A. Influence of monosaccharides on the infection of vertebrate cells by Trypanosoma cruzi and Toxoplasma gondii. Mol Biochem Parasitol. 1982;3:333–341. - PubMed
- Dobrowolski J M, Carruthers V B, Sibley L D. Participation of myosin in gliding motility and host cell invasion by Toxoplasma gondii. Mol Microbiol. 1997;26:163–173. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources